Terms: = Leukemia AND MED12, Q93074, TRAP230, TNRC11, OKS, KIAA0192, HOPA, FGS1, CAGH45, ARC240, 9968
23 results:
1. Enhancer-activated RET confers protection against oxidative stress to KMT2A-rearranged acute myeloid leukemia.
Frett B; Stephens KE; Koss B; Melnyk S; Farrar J; Saha D; Roy Choudhury S
Cancer Sci; 2024 Mar; 115(3):963-973. PubMed ID: 38226414
[TBL] [Abstract] [Full Text] [Related]
2. The protein landscape of chronic lymphocytic leukemia.
Meier-Abt F; Lu J; Cannizzaro E; Pohly MF; Kummer S; Pfammatter S; Kunz L; Collins BC; Nadeu F; Lee KS; Xue P; Gwerder M; Roiss M; Hüllein J; Scheinost S; Dietrich S; Campo E; Huber W; Aebersold R; Zenz T
Blood; 2021 Dec; 138(24):2514-2525. PubMed ID: 34189564
[TBL] [Abstract] [Full Text] [Related]
3. Epigenetic analysis reveals significant differential expression of miR-378C and miR-128-2-5p in a cohort of relapsed pediatric B-acute lymphoblastic leukemia cases.
Bhatia P; Singh M; Singh A; Sharma P; Trehan A; Varma N
Int J Lab Hematol; 2021 Oct; 43(5):1016-1023. PubMed ID: 33538126
[TBL] [Abstract] [Full Text] [Related]
4. Clonal dynamics in a composite chronic lymphocytic leukemia and hairy cell leukemia-variant.
Locher M; Jukic E; Bohn JP; Untergasser G; Steurer M; Cramer CA; Schwendinger S; Vogi V; Verdorfer I; Witsch-Baumgartner M; Nachbaur D; Gunsilius E; Wolf D; Zschocke J; Steiner N
Genes Chromosomes Cancer; 2021 Apr; 60(4):287-292. PubMed ID: 33277788
[TBL] [Abstract] [Full Text] [Related]
5. Predictive significance of selected gene mutations in relapsed and refractory chronic lymphocytic leukemia patients treated with ibrutinib.
Machnicki MM; Górniak P; Pępek M; Szymczyk A; Iskierka-Jażdżewska E; Steckiewicz P; Bluszcz A; Rydzanicz M; Hus M; Płoski R; Makuch-Łasica H; Nowak G; Juszczyński P; Jamroziak K; Stokłosa T; Puła B
Eur J Haematol; 2021 Mar; 106(3):320-326. PubMed ID: 33190294
[TBL] [Abstract] [Full Text] [Related]
6. Initial steps in reconstruction of the human ovary: survival of pre-antral stage follicles in a decellularized human ovarian scaffold.
Pors SE; Ramløse M; Nikiforov D; Lundsgaard K; Cheng J; Andersen CY; Kristensen SG
Hum Reprod; 2019 Aug; 34(8):1523-1535. PubMed ID: 31286144
[TBL] [Abstract] [Full Text] [Related]
7. Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinically.
Mrózek K; Eisfeld AK; Kohlschmidt J; Carroll AJ; Walker CJ; Nicolet D; Blachly JS; Bill M; Papaioannou D; Wang ES; Uy GL; Kolitz JE; Powell BL; Blum W; Stone RM; Byrd JC; Bloomfield CD
Leukemia; 2019 Jul; 33(7):1620-1634. PubMed ID: 30737482
[TBL] [Abstract] [Full Text] [Related]
8. Factors targeting
Bullerdiek J; Rommel B
F1000Res; 2018; 7():359. PubMed ID: 30647905
[TBL] [Abstract] [Full Text] [Related]
9. Modified enzyme multiplied immunoassay technique of methotrexate assay to improve sensitivity and reduce cost.
Shi X; Gao H; Li Z; Li J; Liu Y; Li L; Zhang Q
BMC Pharmacol Toxicol; 2019 Jan; 20(1):3. PubMed ID: 30626430
[TBL] [Abstract] [Full Text] [Related]
10. Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia.
De Bie J; Demeyer S; Alberti-Servera L; Geerdens E; Segers H; Broux M; De Keersmaecker K; Michaux L; Vandenberghe P; Voet T; Boeckx N; Uyttebroeck A; Cools J
Leukemia; 2018 Jun; 32(6):1358-1369. PubMed ID: 29740158
[TBL] [Abstract] [Full Text] [Related]
11. Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses.
Vaisitti T; Braggio E; Allan JN; Arruga F; Serra S; Zamò A; Tam W; Chadburn A; Furman RR; Deaglio S
Cancer Res; 2018 Jul; 78(13):3413-3420. PubMed ID: 29735551
[TBL] [Abstract] [Full Text] [Related]
12. Oncogenic exon 2 mutations in Mediator subunit med12 disrupt allosteric activation of cyclin C-CDK8/19.
Park MJ; Shen H; Spaeth JM; Tolvanen JH; Failor C; Knudtson JF; McLaughlin J; Halder SK; Yang Q; Bulun SE; Al-Hendy A; Schenken RS; Aaltonen LA; Boyer TG
J Biol Chem; 2018 Mar; 293(13):4870-4882. PubMed ID: 29440396
[TBL] [Abstract] [Full Text] [Related]
13. med12 mutations and NOTCH signalling in chronic lymphocytic leukaemia.
Wu B; Słabicki M; Sellner L; Dietrich S; Liu X; Jethwa A; Hüllein J; Walther T; Wagner L; Huang Z; Zapatka M; Zenz T
Br J Haematol; 2017 Nov; 179(3):421-429. PubMed ID: 28771672
[TBL] [Abstract] [Full Text] [Related]
14. Panel oks CAR T Therapy for leukemia.
Cancer Discov; 2017 Sep; 7(9):924. PubMed ID: 28751490
[TBL] [Abstract] [Full Text] [Related]
15. Somatic med12 Nonsense Mutation Escapes mRNA Decay and Reveals a Motif Required for Nuclear Entry.
Heikkinen T; Kämpjärvi K; Keskitalo S; von Nandelstadh P; Liu X; Rantanen V; Pitkänen E; Kinnunen M; Kuusanmäki H; Kontro M; Turunen M; Mäkinen N; Taipale J; Heckman C; Lehti K; Mustjoki S; Varjosalo M; Vahteristo P
Hum Mutat; 2017 Mar; 38(3):269-274. PubMed ID: 28054750
[TBL] [Abstract] [Full Text] [Related]
16. Genomic Profile of Chronic Lymphocytic leukemia in Korea Identified by Targeted Sequencing.
Kim JA; Hwang B; Park SN; Huh S; Im K; Choi S; Chung HY; Huh J; Seo EJ; Lee JH; Bang D; Lee DS
PLoS One; 2016; 11(12):e0167641. PubMed ID: 27959900
[TBL] [Abstract] [Full Text] [Related]
17. Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations.
Spinella JF; Cassart P; Richer C; Saillour V; Ouimet M; Langlois S; St-Onge P; Sontag T; Healy J; Minden MD; Sinnett D
Oncotarget; 2016 Oct; 7(40):65485-65503. PubMed ID: 27602765
[TBL] [Abstract] [Full Text] [Related]
18. Suppression of BCL2 by Antisense Oligonucleotides and Compensation by Non-Targeted Genes May Enhance Tumor Proliferation.
Rubenstein M; Hollowell CM; Guinan P
In Vivo; 2015; 29(6):687-93. PubMed ID: 26546525
[TBL] [Abstract] [Full Text] [Related]
19. Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL.
Guièze R; Robbe P; Clifford R; de Guibert S; Pereira B; Timbs A; Dilhuydy MS; Cabes M; Ysebaert L; Burns A; Nguyen-Khac F; Davi F; Véronèse L; Combes P; Le Garff-Tavernier M; Leblond V; Merle-Béral H; Alsolami R; Hamblin A; Mason J; Pettitt A; Hillmen P; Taylor J; Knight SJ; Tournilhac O; Schuh A
Blood; 2015 Oct; 126(18):2110-7. PubMed ID: 26316624
[TBL] [Abstract] [Full Text] [Related]
20. Somatic med12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia.
Kämpjärvi K; Järvinen TM; Heikkinen T; Ruppert AS; Senter L; Hoag KW; Dufva O; Kontro M; Rassenti L; Hertlein E; Kipps TJ; Porkka K; Byrd JC; de la Chapelle A; Vahteristo P
Oncotarget; 2015 Jan; 6(3):1884-8. PubMed ID: 25595892
[TBL] [Abstract] [Full Text] [Related]
[Next]
